Found: 8
Select item for more details and to access through your institution.
A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1374136
- By:
- Publication type:
- Article
A systematic review and network meta-analysis of first-line immune checkpoint inhibitor combination therapies in patients with advanced non-squamous non-small cell lung cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.948597
- By:
- Publication type:
- Article
Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-11916-4
- By:
- Publication type:
- Article
Cost-effectiveness and potential budget impact of non-pharmacological interventions for early management in prehypertensive people: an economic evaluation for China.
- Published in:
- BMC Public Health, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12889-023-16458-1
- By:
- Publication type:
- Article
Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug Pricing.
- Published in:
- BioDrugs, 2023, v. 37, n. 3, p. 421, doi. 10.1007/s40259-023-00586-6
- By:
- Publication type:
- Article
A network meta-analysis of efficacy and safety for first-line and second/further-line therapies in postmenopausal women with hormone receptor-positive, HER2-negative, advanced breast cancer.
- Published in:
- BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-023-03238-2
- By:
- Publication type:
- Article
Cost-effectiveness analysis of sintilimab vs. placebo in combination with chemotherapy as first-line therapy for local advanced or metastatic oesophageal squamous cell carcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 01, doi. 10.3389/fonc.2022.953671
- By:
- Publication type:
- Article
Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00487-z
- By:
- Publication type:
- Article